Pipamperone

42 interactions 3 explained in plain English

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Moxifloxacin Oxaliplatin Injection Lenvatinib Inotuzumab Ozogamicin Injection Histrelin Implant Ketoconazole Topical

42 Major

All (42) Major (42)

Major

Pipamperone Sertraline Explained An increased risk of QT interval prolongation Details Pipamperone Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Pipamperone Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Pipamperone Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Pipamperone Arsenic Trioxide Trisenox Increased risk of QT-interval prolongation and torsade de pointes Details Pipamperone Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Pipamperone Arsenic Trioxide Injection Trisenox Increased risk of QT-interval prolongation and torsade de pointes Details Pipamperone Asenapine Transdermal Patch Secuado Increased risk of QT interval prolongation Details Pipamperone Azithromycin AzaSite An increased risk of QT interval prolongation and torsade de pointes Details Pipamperone Cabergoline Dostinex® Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Pipamperone Anagrelide Agrylin Increased risk of QT interval prolongation Details Pipamperone Bedaquiline Sirturo Increased risk of QT interval prolongation Details Pipamperone Dasatinib Phyrago An increased risk of QT interval prolongation Details Pipamperone Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Pipamperone Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Pipamperone Dofetilide Tikosyn An increased risk of QT interval prolongation Details Pipamperone Encorafenib Braftovi Increased risk of QT interval prolongation Details Pipamperone Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Pipamperone Foscarnet Injection Foscavir Increased risk of QT interval prolongation Details Pipamperone Fostemsavir Rukobia Increased risk of torsade de pointes Details Pipamperone Glasdegib Daurismo Increased risk of QT interval prolongation Details Pipamperone Goserelin Implant Zoladex Increased risk of QT interval prolongation Details Pipamperone Histrelin Implant Supprelin Increased risk of QT interval prolongation Details Pipamperone Hydroxychloroquine Plaquenil An increased risk of seizures and an increased risk of QT interval prolongation Details Pipamperone Inotuzumab Ozogamicin Injection Besponsa Increased risk of QT interval prolongation Details Pipamperone Ketoconazole Topical Extina® Foam Increased risk of QT interval prolongation Details Pipamperone Lefamulin Xenleta Increased risk of QT interval prolongation Details Pipamperone Lenvatinib Lenvima Increased risk of QT-interval prolongation Details Pipamperone Levodopa Oral Inhalation Inbrija Reduced efficacy of levodopa and an increased risk of exacerbating psychosis (or symptoms of Parkinson's disease: delusion, confus... Details Pipamperone Levofloxacin Levaquin Increased risk of QT interval prolongation Details Pipamperone Levofloxacin Injection Levaquin Increased risk of QT interval prolongation Details Pipamperone Lithium Carbonate Lithobid Weakness, dyskinesias, increased extrapyramidal symptoms, encephalopathy, and brain damage Details Pipamperone Loperamide Diamode An increased risk of QT interval prolongation, which may increase risk of cardiotoxicity (torsade de pointes, cardiac arrest) Details Pipamperone Metronidazole Flagyl An increased risk of QT interval prolongation Details Pipamperone Metronidazole Injection Flagyl An increased risk of QT interval prolongation Details Pipamperone Metronidazole Topical MetroCream® An increased risk of QT interval prolongation Details Pipamperone Metronidazole Vaginal MetroGel® Vaginal An increased risk of QT interval prolongation Details Pipamperone Moxifloxacin Avelox Increased risk of QT interval prolongation Details Pipamperone Moxifloxacin Injection Avelox Increased risk of QT interval prolongation Details Pipamperone Moxifloxacin Ophthalmic Moxeza® Increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.